Line Nederby
Overview
Explore the profile of Line Nederby including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nederby L, Trabjerg N, Andersen A, Lindebjerg J, Hansen T, Rahr H
Clin Colorectal Cancer
. 2024 Aug;
23(4):372-381.e1.
PMID: 39095270
Background: Surgical trauma causes immune impairment, but it is largely unknown whether surgery for cancer and benign diseases instigate comparable levels of immune inhibition. Here, we compared the impact of...
2.
Brun S, Hansen T, Wen S, Nyhus C, Bertelsen L, Jakobsen A, et al.
Sci Rep
. 2024 Apr;
14(1):8993.
PMID: 38637655
Many studies have focused on the prognostic role of soluble programmed death ligand 1 (sPD-L1) in non-small cell lung cancer (NSCLC), but outcomes are ambiguous and further investigations are needed....
3.
Dempsey P, Sandu C, Gonzalezirias R, Hantula S, Covarrubias-Zambrano O, Bossmann S, et al.
Commun Med (Lond)
. 2024 Mar;
4(1):37.
PMID: 38443590
Background: Lung cancer is associated with the greatest cancer mortality as it typically presents with incurable distributed disease. Biomarkers relevant to risk assessment for the detection of lung cancer continue...
4.
Wen S, Nederby L, Andersen R, Hansen T, Nyhus C, Hilberg O, et al.
Br J Cancer
. 2023 May;
129(1):135-142.
PMID: 37137997
Background: PD-1/PD-L1 inhibitors have improved survival for patients with non-small cell lung cancer (NSCLC). We evaluated natural killer cell activity (NKA) and methylated HOXA9 circulating tumor DNA (ctDNA) as prognostic...
5.
Borg M, Nederby L, Wen S, Hansen T, Jakobsen A, Andersen R, et al.
Cancer Biomark
. 2022 Nov;
36(1):63-69.
PMID: 36404535
Background: There is an urgent need for early detection of lung cancer. Screening with low-dose computed tomography (LDCT) is now implemented in the US. Supplementary use of a lung cancer...
6.
Iversen K, Nederby L, Lund T, Plesner T
Clin Hematol Int
. 2022 Sep;
4(3):107-116.
PMID: 36131131
Multiple myeloma is an incurable disease characterized by unregulated growth of malignant plasma cells in the bone marrow (BM). Tumor-induced dysfunction of T-cells may be responsible for immune evasion and...
7.
Borg M, Wen S, Hansen T, Jakobsen A, Andersen R, Hilberg O, et al.
J Int Med Res
. 2022 Jun;
50(6):3000605221108924.
PMID: 35770523
Objective: Natural killer (NK) cells play an essential role in the immune response against cancer. However, immune escape mechanisms may cause inferior NK cell activity (NKA) in patients with cancer....
8.
Simonsen A, Meggendorfer M, Hansen M, Nederby L, Koch S, Hansen M, et al.
Exp Hematol
. 2022 Feb;
107:51-59.
PMID: 35122908
Next-generation sequencing (NGS) is an excellent methodology for measuring residual disease in acute myeloid leukemia and surveying several subclones simultaneously. There is little experience with interpretation of differential clonal responses...
9.
Wen S, Andersen R, Rasmussen K, Thomsen C, Hansen T, Nederby L, et al.
Cancers (Basel)
. 2021 Aug;
13(16).
PMID: 34439376
Diagnosing lung cancer requires invasive procedures with high risk of complications. Methylated tumor DNA in bronchial lavage has previously shown potential as a diagnostic biomarker. We aimed to develop and...
10.
Borg M, Wen S, Nederby L, Hansen T, Jakobsen A, Andersen R, et al.
Lung Cancer
. 2021 Jun;
158:85-90.
PMID: 34130044
Objectives: Early detection of lung cancer is pivotal for an optimal prognosis. CT screening is currently implemented in USA. To decrease the amount of CT scans, the application of a...